Skip to main content
SpringerLink
Log in

Uncommon Tumors and Mimickers of Cancer

  • Chapter
  • First Online:
Challenging Cases in Gynecologic Surgical Pathology

  • 70 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Koenig C, Tavassoli FA. Nodular hyperplasia, adenoma, and adenomyoma of Bartholin’s gland. Int J Gynecol Pathol. 1998;17(4):289–94.

    Article  CAS  PubMed  Google Scholar 

  2. Santos LD, Kennerson AR, Killingsworth MC. Nodular hyperplasia of Bartholin’s gland. Pathology. 2006;38(3):223–8.

    Article  PubMed  Google Scholar 

  3. Tseng YA, Lawrence WD, Slater SE. Nodular hyperplasia of the Bartholin gland, a benign mimicker of aggressive angiomyxoma: a case series and literature review. Int J Gynecol Pathol. 2018;37(6):554–8.

    Article  PubMed  Google Scholar 

  4. Barcellini A, Gadducci A, Laliscia C, Imparato S, Vitolo V, Preda L, et al. Adenoid cystic carcinoma of Bartholin’s gland: what is the best approach? Oncology. 2020;98(8):513–9.

    Article  PubMed  Google Scholar 

  5. Helmi Z, Nori W, Ghani Zghair MA, AbdulrahmanHadi BA. Bartholin gland carcinoma: a case report. J Pak Med Assoc. 2021;71(Suppl 9)(12):S86–8.

    Google Scholar 

  6. Bhalwal AB, Nick AM, Dos Reis R, Chen CL, Munsell MF, Ramalingam P, et al. Carcinoma of the Bartholin gland: a review of 33 cases. Int J Gynecol Cancer. 2016;26(4):785–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wang W, Chen H, Guo H, Chen L, Zhu M, Zhu Y. Adenoid cystic carcinoma of the Bartholin's gland is easily misdiagnosed: a case report and literature review. Medicine (Baltimore). 2022;101(45):e31744.

    Article  PubMed  Google Scholar 

  8. Scinicariello F, Rady P, Hannigan E, Dinh TV, Tyring SK. Human papillomavirus type 16 found in primary transitional cell carcinoma of the Bartholin’s gland and in a lymph node metastasis. Gynecol Oncol. 1992;47(2):263–6.

    Article  CAS  PubMed  Google Scholar 

  9. Nazeran T, Cheng AS, Karnezis AN, Tinker AV, Gilks CB. Bartholin gland carcinoma: clinicopathologic features, including p16 expression and clinical outcome. Int J Gynecol Pathol. 2019;38(2):189–95.

    Article  CAS  PubMed  Google Scholar 

  10. El-Khoury J, Renald MH, Plantier F, Avril MF, Moyal-Barracco M. Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): analysis of the photographs of 52 tumors. J Am Acad Dermatol. 2016;75(2):380–4.

    Article  PubMed  Google Scholar 

  11. Konstantinova AM, Michal M, Kacerovska D, Spagnolo DV, Stewart CJ, Kutzner H, et al. Hidradenoma papilliferum: a clinicopathologic study of 264 tumors from 261 patients, with emphasis on mammary-type alterations. Am J Dermatopathol. 2016;38(8):598–607.

    Article  PubMed  Google Scholar 

  12. Sington J, Chandrapala R, Manek S, Hollowood K. Mitotic count is not predictive of clinical behavior in hidradenoma papilliferum of the vulva: a clinicopathologic study of 19 cases. Am J Dermatopathol. 2006;28(4):322–6.

    Article  PubMed  Google Scholar 

  13. Goto K, Maeda D, Kudo-Asabe Y, Hibiya T, Hayashi A, Fukayama M, et al. PIK3CA and AKT1 mutations in hidradenoma papilliferum. J Clin Pathol. 2017;70(5):424–7.

    Article  CAS  PubMed  Google Scholar 

  14. Pelosi G, Martignoni G, Bonetti F. Intraductal carcinoma of mammary-type apocrine epithelium arising within a papillary hydradenoma of the vulva. Report of a case and review of the literature. Arch Pathol Lab Med. 1991;115(12):1249–54.

    CAS  PubMed  Google Scholar 

  15. Kim GY, Solanki MH, Guo R. Vulvar apocrine hidradenocarcinoma arising in a hidradenoma papilliferum-A case report. J Cutan Pathol. 2021;48(8):1085–7.

    Article  PubMed  Google Scholar 

  16. Brown ST, Nalley JF, Kraus SJ. Molluscum contagiosum. Sex Transm Dis. 1981;8(3):227–34.

    Article  CAS  PubMed  Google Scholar 

  17. Sand FL, Thomsen SF. Skin diseases of the vulva: infectious diseases. J Obstet Gynaecol. 2017;37(7):840–8.

    Article  PubMed  Google Scholar 

  18. Epstein WL. Molluscum contagiosum. Semin Dermatol. 1992;11(3):184–9.

    CAS  PubMed  Google Scholar 

  19. Chen W, Koenig C. Vulvar keratoacanthoma: a report of two cases. Int J Gynecol Pathol. 2004;23(3):284–6.

    Article  PubMed  Google Scholar 

  20. Misago N, Inoue T, Koba S, Narisawa Y. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification. J Dermatol. 2013;40(6):443–52.

    Article  PubMed  Google Scholar 

  21. Orosz Z, Lehoczky O, Szoke J, Pulay T. Recurrent giant fibroepithelial stromal polyp of the vulva associated with congenital lymphedema. Gynecol Oncol. 2005;98(1):168–71.

    Article  PubMed  Google Scholar 

  22. Piqué-Duran E, Palacios-Llopis S, Moreno-Ramis P, Pérez-Cejudo JA, Martínez-Martín MS. Comparative study of pagetoid dyskeratosis between acrochordons and soft fibromas. Am J Dermatopathol. 2006;28(6):478–81.

    Article  PubMed  Google Scholar 

  23. Nucci MR, Young RH, Fletcher CD. Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an underrecognized lesion often misdiagnosed as sarcoma. Am J Surg Pathol. 2000;24(2):231–40.

    Article  CAS  PubMed  Google Scholar 

  24. Nucci MR. Mesenchymal lesions of the lower genital tract. Surg Pathol Clin. 2009;2(4):603–23.

    Article  PubMed  Google Scholar 

  25. Schoolmeester JK, Fritchie KJ. Genital soft tissue tumors. J Cutan Pathol. 2015;42(7):441–51.

    Article  PubMed  Google Scholar 

  26. Calonje E, Guerin D, McCormick D, Fletcher CD. Superficial angiomyxoma: clinicopathologic analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence. Am J Surg Pathol. 1999;23(8):910–7.

    Article  CAS  PubMed  Google Scholar 

  27. Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol. 2001;25(6):809–14.

    Article  CAS  PubMed  Google Scholar 

  28. Le BH, Boyer PJ, Lewis JE, Kapadia SB. Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation. Arch Pathol Lab Med. 2004;128(7):771–5.

    Article  CAS  PubMed  Google Scholar 

  29. Schoolmeester JK, Michal M, Steiner P, Michal M, Folpe AL, Sukov WR. Lipoblastoma-like tumor of the vulva: a clinicopathologic, immunohistochemical, fluorescence in situ hybridization and genomic copy number profiling study of seven cases. Mod Pathol. 2018;31(12):1862–8.

    Article  CAS  PubMed  Google Scholar 

  30. McCluggage WG, Ganesan R, Hirschowitz L, Rollason TP. Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described. Histopathology. 2004;45(4):360–8.

    Article  CAS  PubMed  Google Scholar 

  31. Chen E, Fletcher CD. Cellular angiofibroma with atypia or sarcomatous transformation: clinicopathologic analysis of 13 cases. Am J Surg Pathol. 2010;34(5):707–14.

    Article  PubMed  Google Scholar 

  32. Maggiani F, Debiec-Rychter M, Vanbockrijck M, Sciot R. Cellular angiofibroma: another mesenchymal tumour with 13q14 involvement, suggesting a link with spindle cell lipoma and (extra)-mammary myofibroblastoma. Histopathology. 2007;51(3):410–2.

    Article  CAS  PubMed  Google Scholar 

  33. Panagopoulos I, Gorunova L, Bjerkehagen B, Andersen K, Lund-Iversen M, Heim S. Loss of chromosome 13 material in cellular angiofibromas indicates pathogenetic similarity with spindle cell lipomas. Diagn Pathol. 2017;12(1):17.

    Article  PubMed  PubMed Central  Google Scholar 

  34. McCluggage WG, Perenyei M, Irwin ST. Recurrent cellular angiofibroma of the vulva. J Clin Pathol. 2002;55(6):477–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Agaram NP, Prakash S, Antonescu CR. Deep-seated plexiform schwannoma: a pathologic study of 16 cases and comparative analysis with the superficial variety. Am J Surg Pathol. 2005;29(8):1042–8.

    Article  PubMed  Google Scholar 

  36. Meyer A, Billings SD. What’s new in nerve sheath tumors. Virchows Arch. 2020;476(1):65–80.

    Article  PubMed  Google Scholar 

  37. Azurah AG, Grover S, McGregor D. Plexiform schwannoma of the clitoris in a young girl: a case report. J Reprod Med. 2013;58(7–8):365–8.

    PubMed  Google Scholar 

  38. Cohen JN, Yeh I, LeBoit PE. Melanotic schwannoma of the vulva: a case report and review of the literature. Am J Dermatopathol. 2020;42(1):46–51.

    Article  PubMed  Google Scholar 

  39. Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T. Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol. 2003;16(4):293–8.

    Article  PubMed  Google Scholar 

  40. McMenamin ME, Fletcher CD. Expanding the spectrum of malignant change in schwannomas: epithelioid malignant change, epithelioid malignant peripheral nerve sheath tumor, and epithelioid angiosarcoma: a study of 17 cases. Am J Surg Pathol. 2001;25(1):13–25.

    Article  CAS  PubMed  Google Scholar 

  41. Petrilli AM, Fernández-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene. 2016;35(5):537–48.

    Article  CAS  PubMed  Google Scholar 

  42. Liao X, Liu X, Fan X, Lai J, Zhang D. Perianal Paget's disease: a clinicopathological and immunohistochemical study of 13 cases. Diagn Pathol. 2020;15(1):29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Liao X, Mao W, Lin A. Perianal Paget’s disease co-associated with anorectal adenocarcinoma: primary or secondary disease? Case Rep Gastroenterol. 2014;8(2):186–92.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Al-Obaidy KI, Kao CS, Idrees MT. P16 expression in extramammary Paget's disease of the vulva and scrotum is not human papillomavirus related. Int J Surg Pathol. 2018;26(7):617–20.

    Article  CAS  PubMed  Google Scholar 

  45. Konstantinova AM, Shelekhova KV, Stewart CJ, Spagnolo DV, Kutzner H, Kacerovska D, et al. Depth and patterns of adnexal involvement in primary extramammary (anogenital) Paget disease: a study of 178 lesions from 146 patients. Am J Dermatopathol. 2016;38(11):802–8.

    Article  PubMed  Google Scholar 

  46. Konstantinova AM, Kazakov DV. Extramammary Paget disease of the vulva. Semin Diagn Pathol. 2021;38(1):50687.

    Article  PubMed  Google Scholar 

  47. van der Linden M, Oonk MHM, van Doorn HC, Bulten J, van Dorst EBL, Fons G, et al. Vulvar Paget disease: a national retrospective cohort study. J Am Acad Dermatol. 2019;81(4):956–62.

    Article  PubMed  Google Scholar 

  48. Namuduri RP, Lim TY, Yam PK, Gatsinga R, Lim-Tan SK, Chew SH, et al. Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre. Singap Med J. 2019;60(9):479–82.

    Article  Google Scholar 

  49. Flipo R, Bani MA, Rejaibi S, Talhi N, Sastre-Garau X. Vulvar basal cell carcinoma: clinical and histopathologic features. Int J Gynecol Pathol. 2022;41(1):86–92.

    Article  CAS  PubMed  Google Scholar 

  50. Santos M, Montagut C, Mellado B, García A, Ramón y Cajal S, Cardesa A, et al. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol. 2004;23(3):206–14.

    Article  PubMed  Google Scholar 

  51. Zhu J, Yin L, Wang Q, Wu X, Ke G. Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience. Int J Clin Oncol. 2020;25(12):2144–50.

    Article  PubMed  Google Scholar 

  52. Xing D, Schoolmeester JK, Ren Z, Isacson C, Ronnett BM. Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection. Am J Surg Pathol. 2016;40(4):529–36.

    Article  PubMed  Google Scholar 

  53. Nieuwenhuyzen-de Boer GM, Dasgupta S, Ewing-Graham PC, Van Bockstal MR. Adenoid cystic carcinoma of the Bartholin gland is not HPV-related: a case report and review of literature. Pathol Res Pract. 2020;216(6):152968.

    Article  CAS  PubMed  Google Scholar 

  54. Winkelmann SE, Llorens AS. Metastatic basal cell carcinoma of the vulva. Gynecol Oncol. 1990;38(1):138–40.

    Article  CAS  PubMed  Google Scholar 

  55. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol. 2008;27(1):125–35.

    Article  PubMed  Google Scholar 

  56. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol. 2000;24(3):429–41.

    Article  CAS  PubMed  Google Scholar 

  57. Singh N, Leen SL, Han G, Faruqi A, Kokka F, Rosenthal A, et al. Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss. Am J Surg Pathol. 2015;39(1):52–60.

    Article  PubMed  Google Scholar 

  58. Liu YA, Ji JX, Almadani N, Crawford RI, Gilks CB, Kinloch M, et al. Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva. Histopathology. 2021;78(3):424–33.

    Article  PubMed  Google Scholar 

  59. Dasgupta S, Koljenović S, van den Bosch TPP, Swagemakers SMA, van der Hoeven NMA, van Marion R, et al. Evaluation of immunohistochemical markers, CK17 and SOX2, as adjuncts to p53 for the diagnosis of differentiated vulvar intraepithelial neoplasia (dVIN). Pharmaceuticals (Basel). 2021;14(4).

    Google Scholar 

  60. Heller DS, Day T, Allbritton JI, Scurry J, Radici G, Welch K, et al. Diagnostic criteria for differentiated vulvar intraepithelial neoplasia and vulvar aberrant maturation. J Low Genit Tract Dis. 2021;25(1):57–70.

    Article  PubMed  Google Scholar 

  61. Medeiros F, Nascimento AF, Crum CP. Early vulvar squamous neoplasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol. 2005;12(1):20–6.

    Article  PubMed  Google Scholar 

  62. van de Nieuwenhof HP, Bulten J, Hollema H, Dommerholt RG, Massuger LF, van der Zee AG, et al. Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma. Mod Pathol. 2011;24(2):297–305.

    Article  PubMed  Google Scholar 

  63. Bradford J, Fischer G. Management of vulvovaginal lichen planus: a new approach. J Low Genit Tract Dis. 2013;17(1):28–32.

    Article  PubMed  Google Scholar 

  64. Watkins JC, Yang E, Crum CP, Herfs M, Gheit T, Tommasino M, et al. Classic vulvar intraepithelial neoplasia with superimposed lichen simplex chronicus: a unique variant mimicking differentiated vulvar intraepithelial neoplasia. Int J Gynecol Pathol. 2019;38(2):175–82.

    Article  PubMed  Google Scholar 

  65. Dong F, Kojiro S, Borger DR, Growdon WB, Oliva E. Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR). Am J Surg Pathol. 2015;39(8):1045–53.

    Article  PubMed  Google Scholar 

  66. Granter SR, Nucci MR, Fletcher CD. Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases. Histopathology. 1997;30(1):3–10.

    Article  CAS  PubMed  Google Scholar 

  67. McCluggage WG, Patterson A, Maxwell P. Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity. J Clin Pathol. 2000;53(8):603–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Medeiros F, Erickson-Johnson MR, Keeney GL, Clayton AC, Nascimento AG, Wang X, et al. Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower genital tract. Genes Chromosomes Cancer. 2007;46(11):981–90.

    Article  CAS  PubMed  Google Scholar 

  69. Laskin WB, Fetsch JF, Tavassoli FA. Angiomyofibroblastoma of the female genital tract: analysis of 17 cases including a lipomatous variant. Hum Pathol. 1997;28(9):1046–55.

    Article  CAS  PubMed  Google Scholar 

  70. Fritchie KJ, Goldblum JR, Tubbs RR, Sun Y, Carver P, Billings SD, et al. The expanded histologic spectrum of myxoidliposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens. Am J Clin Pathol. 2012;137(2):229–39.

    Article  PubMed  Google Scholar 

  71. Hollowood K, Fletcher CD. Soft tissue sarcomas that mimic benign lesions. Semin Diagn Pathol. 1995;12(1):87–97.

    CAS  PubMed  Google Scholar 

  72. Nappi O, Wick MR, Pettinato G, Ghiselli RW, Swanson PE. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol. 1992;16(5):429–38.

    Article  CAS  PubMed  Google Scholar 

  73. Horn LC, Liebert UG, Edelmann J, Höckel M, Einenkel J. Adenoid squamous carcinoma (pseudoangiosarcomatous carcinoma) of the vulva: a rare but highly aggressive variant of squamous cell carcinoma-report of a case and review of the literature. Int J Gynecol Pathol. 2008;27(2):288–91.

    PubMed  Google Scholar 

  74. Giordano G, D’Adda T, Merisio C, Gnetti L. Vulvar acantholytic squamous carcinoma: a case report with immunohistochemical and molecular study. Int J Gynecol Pathol. 2005;24(3):303–6.

    Article  PubMed  Google Scholar 

  75. Bayer-Garner IB, Smoller BR. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma. J Cutan Pathol. 2001;28(2):83–9.

    Article  CAS  PubMed  Google Scholar 

  76. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22(6):683–97.

    Article  CAS  PubMed  Google Scholar 

  77. Kartono F, Shitabata PK, Magro CM, Rayhan D. Discohesive malignant melanoma simulating a bullous dermatoses. J Cutan Pathol. 2009;36(2):274–9.

    Article  PubMed  Google Scholar 

  78. Nagore E, Sánchez-Motilla JM, Pérez-Vallés A, Martínez-Lahuerta C, Alegre V, Aliaga A. Pseudovascular squamous cell carcinoma of the skin. Clin Exp Dermatol. 2000;25(3):206–8.

    Article  CAS  PubMed  Google Scholar 

  79. Kiyohara T, Miyamoto M, Shijimaya T, Nagano N, Nakamaru S, Makimura K, et al. Pseudovascular squamous cell carcinoma: a review of the published work and reassessment of prognosis. J Dermatol. 2018;45(12):1448–51.

    Article  PubMed  Google Scholar 

  80. Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32(6):924–7.

    Article  PubMed  Google Scholar 

  81. Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2013;52(8):775–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. 2011;50(8):644–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open. 2021;6(3):100170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Miettinen M, Fetsch JF. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis. Hum Pathol. 2000;31(9):1062–7.

    Article  CAS  PubMed  Google Scholar 

  85. Righi A, Sbaraglia M, Gambarotti M, Gibertoni D, Rovira MP, Benini S, et al. Primary vascular tumors of bone: a monoinstitutional morphologic and molecular analysis of 427 cases with emphasis on epithelioid variants. Am J Surg Pathol. 2020;44(9):1192–203.

    Article  PubMed  Google Scholar 

  86. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009;33(4):542–50.

    Article  PubMed  Google Scholar 

  87. Rosenbaum E, Jadeja B, Xu B, Zhang L, Agaram NP, Travis W, et al. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets. Mod Pathol. 2020;33(4):591–602.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA

    Ozlen Saglam

Authors
  1. Ozlen Saglam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozlen Saglam .

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saglam, O. (2023). Uncommon Tumors and Mimickers of Cancer. In: Challenging Cases in Gynecologic Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-51656-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-51656-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-51655-9

  • Online ISBN: 978-3-031-51656-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation